Expand IBB Menu
IBB MENU

IBB ETF Profile


Family: Blackrock (iShares)
Name: iShares Biotechnology ETF
Inception Date: 5-Feb-2001
Termination Date:
Investment Objective: The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector. It provides exposure to U.S. companies in the biotechnology industry.
Prospectus
Top 10 Holdings
AMGEN INC AMGN 8.6501%
VERTEX PHARMACEUTICALS INC VRTX 8.3334%
REGENERON PHARMACEUTICALS INC REGN 8.1325%
GILEAD SCIENCES INC GILD 8.0503%
IQVIA HOLDINGS INC IQV 4.5162%
MODERNA INC MRNA 3.8138%
BIOGEN INC BIIB 2.9361%
METTLER TOLEDO INC MTD 2.7667%
ILLUMINA INC ILMN 2.0753%
ARGENX SE ADR ARGX 1.9832%
Top 10 Holdings Weight: 51.3%
Number of Holdings: 225
Shares Outstanding: 55,550,000
Total Net Assets: 7,111,511,000
NAV: 128.06
Net Expense Ratio: 0.45%
Asset Class: Equities (Stocks)
Developed or Emerging: Developed Market Funds
Country: US
Region:
Strategy:
Currency:
Commodity:
Sector: Healthcare
Industry: Biotech
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap: Large & Mid Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor:
Is Currency Hedged: No
US or Ex-US: Domestic